Neurofeedback News:

Attention Deficit Disorder / Attention Deficit Hyperactive Disorder

Over the past year, several new and exciting news articles and press releases were written regarding the benefits of neurofeedback and qEEG analysis to help with AD/HD.

First, in July of 2013, the FDA approved the marketing of a system to help in the identification of AD/HD in children and young adults. One particular component of the system featured in the FDA news release is an analysis of the Theta/Beta ratio, which is considered a good prognostic measure. The theta/beta ratio has been shown to be higher in children and adolescents with ADHD than in children without it. Through our Alliance with Evoke Neurosciences, we have that analysis (click here for FDA News Release).

On February 17, 2014 the Boston Globe ran a story on the effectiveness of neurofeedback on kids presenting AD/HD symptoms (click here for full article). The story was based on a study performed by the American Academy of Pediatrics (AAP), also published in February (click here for full article).

The conclusion, according to the AAP: “Neurofeedback participants made more prompt and greater improvement in AD/HD symptoms, which were sustained at the 6 month follow up than Cognitive therapy participants or those in the control group.” The finding suggests neurofeedback is a promising attention training treatment for children with ADHD.

As such, the American Academy of Pediatrics placed Neurofeedback (brain biofeedback) as a Level 1 "Best Support" intervention for ADHD (click here).


Below are a few more research articles supporting the effectiveness of neurofeedback:


Electroencephalographic Biofeedback in the Treatment of Attention-Deficit/Hyperactivity Disorder
By: Vincent J. Monastra, Steven Lynn, Michael Linden, Joel F. Lubar, John Gruzelier, and Theodore J. LaVaque

Without effective treatment, children and adolescents with ADHD are at greater risk to develop academic, behavioral, mood, and anxiety disorders (Biederman et al., 1996), incur accidental injury (Hartsough & Lambert, 1985; Lahey et al., 1998), and struggle with substance abuse disorders (Claude & Firestone, 1995; Mannuzza et al., 1991). Similarly, when not systematically treated, adults with a childhood history of ADHD have academic histories marked by lower average marks, more expulsions, a higher rate of retention in a grade, and fewer completed grades (Weiss & echtman, 1993; Mannuzza et al., 1993, 1998). These patients are more likely to have a higher incidence of substance abuse, psychiatric disorders, and criminal behavior, and have an employment history of more jobs, more frequent “layoffs” and an overall job status that was lower than that of peers of similar intelligence without ADHD (Weiss & Hechtman, 1993; Murphy & Barkley, 1996).
For more information, please click the following link:



New Study Supports Neurofeedback Treatment for ADHD
By: Dr. David Rabiner

Neurofeedback — also known as EEG BiofeedĀ­back — is an approach for treating ADHD in which individuals are provided realtime feedĀ­back on their brainwave patterns and taught to alter their typical EEG pattern to one that is consistent with a focused, attentive state. This is typically done by collecting EEG data from individuals as they focus on stimuli presented on a computer screen. Their ability to control the stimuli, for example, keeping the smile on a smiley face, is contingent on maintaining the particular EEG state being trained. According to neurofeedback proponents, learning how to do this during training generalizes to real world situations and this results in improved attention and reduced hyperactive/impulsive behavior.
For more information, please click the following link: